Not financial advice. This site shares one person's personal experience with spending and investing — it is not a recommendation for you. All investing carries risk. Full disclaimer

All weekly buys
Trading 212 (ISA)SharesETFsSpace

SpaceX Exposure via SPCX & Topping Up Johnson & Johnson

4 min read
Trade Summary

The numbers at a glance

What I bought, where I bought it, and how much went in this week.

Platform

Trading 212

Total invested

£200

Buys

1 ETF + 1 Share

For educational purposes only. These are my personal investments. Nothing here is financial advice or a recommendation. All investing carries risk.

Minimalist illustration of an astronaut floating in space above the Earth, symbolising owning the whole world through a single low-cost global ETF
Own the whole world without leaving your sofa. VALL, VSML and VXUS put the entire planet's stock market in one portfolio.

This week I did something slightly different. Two small buys — one ETF I've been curious about for ages, and one individual share I've wanted to own for a while.

First: £100 into the SPCX ETF. This is the SPDR S&P Kensho Space Economy ETF — and yes, it holds SpaceX. Not directly (SpaceX is still private), but through various publicly-traded companies that have SpaceX exposure, plus other space-related companies. Why? Honestly, because I find the space sector fascinating and wanted a tiny piece of it in my portfolio. It's speculative, it's niche, and I know that. That's why it's a small position — £100, about 0.5% of my portfolio. If it goes to zero I'll be annoyed but not hurt. If the space economy takes off over the next 20 years, I've got a seat on the rocket. Is it sensible investing? Debatable. Is it fun? Absolutely. Sometimes you just want to own something interesting.

Second: £100 into Johnson & Johnson (JNJ). This is much more my speed — a boring, established, dividend-paying company that's been around since 1886. JNJ has increased its dividend for over 60 consecutive years. It makes everything from Band-Aids to cancer drugs. It's the kind of company that keeps chugging along regardless of what the economy is doing. The share price has been under a bit of pressure lately — talc litigation, some patent expiries — but I'm not buying for next month or next year. I'm buying for the next decade. At my age, that's either brave or foolish. Time will tell.

So that's £200 total. £100 into a speculative space ETF and £100 into one of the most boring, dependable companies on Earth. Balance, as they say, is everything.

I'm keeping both positions tiny. The SPCX holding is pure curiosity — I want to watch it and learn. The JNJ holding is the start of what might become a larger position if the price stays attractive. But for now, small steps.

As always: this is what I did with my own money. It's not a recommendation. Do your own research. All investing carries risk — you can lose money, and past performance doesn't predict future returns. SPCX is a niche thematic ETF — it's concentrated, it's volatile, and it might not be suitable for most investors. I'm comfortable with the risk because the position is tiny relative to my overall portfolio.

More Weekly Buys

Read next

Trading 212 (SIPP)SharesETFsVUAGMETAAMZNGOOGLASSTStrategyRegular BuyLong Term

SIPP Buy: More VUAG, META, AMZN & GOOGL — Plus a New One Called ASST, Which I Can't Fully Explain Yet!

Another Trading 212 SIPP top-up, and it's four familiar faces plus one I'm still getting my head around. More VUAG — the S&P 500 engine that gets fed every single week without fail. More Meta (META), Amazon (AMZN) and Alphabet (GOOGL) — three of the highest-conviction compounders in the portfolio, all still earning my capital. And a brand-new, deliberately small position in Strive (ASST), which is either a very interesting idea or a very silly one, and I genuinely won't know which for about five years. One index engine, three mega-cap compounders, one tiny experiment. Same plan as always: keep buying the good stuff, keep the experiments small, and let long-term compounding do the heavy lifting. Happy days.

15 Sept 2026Read
Trading 212 (SIPP)StrategyRegular BuyCompoundingLong TermSIPPTrading 212Investing MindsetMotivation

Striving Into Trading 212 SIPP: Little and Often, Beautifully Stuck To — This Whole Habit Just Looks Super Long Term!

A quiet, grateful reflection rather than a single big buy: this is the meta-celebration of the habit itself — week in, week out, striving into the Trading 212 SIPP with more VWRP and VUAG, more of the gigglesome LDGG and RDDT, and a dependable tuck-in of MCD, all on a relaxed little-and-often rhythm. Nothing clever, and that's exactly the point. Consistent contributions, topped up by basic-rate tax relief, left alone, compound into something genuinely life-changing over decades. Here's to the quiet grind that makes us all happy — not this week, but in the long term where the real magic happens. Happy days, and keep striving.

4 Sept 2026Read

For educational purposes only. This content provides general information about spending habits, saving and personal finance. It is not financial advice or a recommendation to take any financial action. Always consider your own circumstances before making financial decisions. This is what I do and it is not investment or financial advice. I am not regulated by the Financial Conduct Authority (FCA) and nothing on this website constitutes regulated financial advice. All content is for educational and informational purposes only. Stocks and investments can go up as well as down. Past performance does not guarantee future results. Always do your own research and seek professional advice where appropriate. I will receive a small commission referral fee from some platforms I mention.